News &amp; Updates

Blue-blocking lenses do little for digital eye strain

Blue-blocking lenses fall short of reducing the ocular signs and symptoms of eye strain associated with computer use, according to a study.

Blue-blocking lenses do little for digital eye strain

Postdischarge phone follow-ups have no benefit on elderly patients’ return to ED

Telephone follow-ups after discharge from the emergency department (ED) have no clear impact on hospital return rates among elderly patients, a recent study has found.

Postdischarge phone follow-ups have no benefit on elderly patients’ return to ED

Linzagolix maintains long-term benefit in women with uterine fibroids

17 Jul 2021 by

Linzagolix treatment continues to reduce menstrual blood loss (MBL) and pain severity, while improving haemoglobin (Hb) level and quality of life (QoL) up to 52 weeks in women with uterine fibroids, according to two phase III randomized clinical trials presented at ESHRE 2021.

Linzagolix maintains long-term benefit in women with uterine fibroids

Social isolation during COVID-19 impacts comorbidities, mental health

Isolation during the COVID-19 pandemic may lead to deterioration in comorbidities and mental health, according to two studies presented at the European Society of Endocrinology virtual conference (e-ECE 2021).

Social isolation during COVID-19 impacts comorbidities, mental health

Implementing sFlt-1/PlGF ratio test for pre-eclampsia cuts unnecessary hospitalizations, costs

The ratio test based on a soluble fms-like tyrosine 1/placental growth factor (sFlt-1/PlGF) cutoff of ≤38 is likely to reduce unnecessary hospitalization in Asian women for pre-eclampsia and improve the identification of those who do need medical attention, leading to substantial cost savings for the healthcare system, reports a recent Japan study.

Implementing sFlt-1/PlGF ratio test for pre-eclampsia cuts unnecessary hospitalizations, costs

Insulin glargine/lixisenatide combo drug trumps biphasic insulin in poorly controlled T2D

Once-daily iGlarLixi is superior to twice-daily premixed biphasic insulin aspart 30 (BIAsp 30) in glycaemic control and reducing body weight, along with less risk of hypoglycaemia, in patients with suboptimally controlled type 2 diabetes (T2D) despite treatment with basal insulin plus oral antihyperglycaemic drugs (OADs), according to the SoliMix trial presented at ADA 2021.

Insulin glargine/lixisenatide combo drug trumps biphasic insulin in poorly controlled T2D

NCCS guidelines for hepatocellular cancer validated in real-world study

The National Cancer Centre Singapore (NCCS) consensus guidelines for staging, prognosticating, and recommending treatment in hepatocellular carcinoma (HCC) appear to have strong applicability to the clinicians and populations for whom they are intended.

NCCS guidelines for hepatocellular cancer validated in real-world study

Pharmacist improves safety, quality of care in onco-haematology, bone marrow transplant units

Pharmacist interventions done in onco-haematology and bone marrow transplant inpatient units have led to improvements in safety and quality of care, results of a recent study have shown.

Pharmacist improves safety, quality of care in onco-haematology, bone marrow transplant units

Wearable patch tracks Doppler blood flow metrics in carotid artery

A novel, hands-free ultrasound patch for continuous monitoring of quantitative Doppler accurately measures flow velocity, is easy to use, and can constantly record Doppler spectrograms over many cardiac and respiratory cycles, a study has shown.

Wearable patch tracks Doppler blood flow metrics in carotid artery